Laurie Mooney, MD
Sleep Medicine · Mount Vernon, OHNPI 1386623999
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,145 of the $2,731 with a category attached, or 78.5%. 13 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 38.7% of the total. 2025 is the largest year on record at $879, more than ten times the $51 reported in 2019.
Across 134 payments — averaging $20.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$1K
- Harmony Biosciences LLC$713
- Axsome Therapeutics, Inc.$376
- ZOLL Respicardia, Inc.$137
- Inspire Medical Systems, Inc.$125
- Avadel CNS Pharmaceuticals, LLC$87
- plus $237 from 7 others
What the payments were for
- Consulting fees$1505%
- Food & beverage$2,14579%
- Education$43716%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 46 | $1,057 |
| Harmony Biosciences LLC | 35 | $713 |
| Axsome Therapeutics, Inc. | 29 | $376 |
| ZOLL Respicardia, Inc. | 2 | $137 |
| Inspire Medical Systems, Inc. | 5 | $125 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $87 |
| Fisher & Paykel Healthcare Inc | 4 | $82 |
| Itamar Medical Inc | 3 | $57 |
| Lilly USA, LLC | 2 | $42 |
| 3b Medical, Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Resmed Corp | 1 | $14 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XYWAV$150
- XYREM$150
- SUNOSI$125
- remede System$106
How this compares
$2,731 in reported general payments places this provider in the 60th percentile of 94 sleep medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SunosiSolriamfetol Hcl | 11 | $8,129 |
| BelsomraSuvorexant | 14 | $6,067 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 21 | $1,827 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 21 | $864 |
| Zolpidem Tartrate ErZolpidem Tartrate | 38 | $756 |
| Ropinirole Hcl | 70 | $719 |
| Modafinil | 20 | $314 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 20 | $263 |
| Zolpidem Tartrate | 67 | $254 |
| Clonazepam | 19 | $252 |
| Temazepam | 14 | $175 |
| Trazodone Hcl | 38 | $140 |
| Eszopiclone | 16 | $139 |
| Alprazolam | 48 | $129 |
| Hydroxyzine Pamoate | 15 | $33 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Axsome Therapeutics, Inc.Sunosi | $376 | $8,12911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 94 sleep medicine providers in Ohio.
Other sleep medicine in Mount Vernon
- Asim RoyDublin$666K
- Shahrokh JavaheriCincinnati$404K
- Louis TartagliaMaumee$314K
- John AndrefskyParma$147K
- Anthony SuchoskiCincinnati$89K
- Nancy Foldvary-SchaeferCleveland$75K
- Shayla PullenCincinnati$71K
- Gautam SamadderColumbus$53K
- Kevin CarterBeavercreek$49K
- Brian ChenCleveland$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.